Trial Profile
Open-label, Single-arm Pilot Study of the Effects of Topical 5% Imiquimod Cream on Preventing Keloid Recurrence After Surgical Keloidectomy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2020
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Keloids
- Focus Therapeutic Use
- 16 Nov 2020 Status changed from suspended to discontinued.
- 10 Sep 2020 Planned End Date changed from 12 Sep 2020 to 1 Sep 2021.
- 10 Sep 2020 Planned primary completion date changed from 12 Sep 2020 to 1 Sep 2021.